Hepatitis Market Research Reports & Industry Analysis

The notion “hepatitis” means inflammation of the liver or its cells, often caused by some virus and accompanied in its initial phase to by symptoms similar to flu: fever, loss of appetite, muscle/joint aches, etc. According to the virus type hepatitis is divided into several types: hepatitis A, В C, D and E. Hepatitis can disappear on its own, but in some cases it can lead to serious liver dysfunctions and severe complications such as fibrosis, liver failure or cancer, cryoglobulinemia, an a lot more.

The world hepatitis drugs market has experienced stable growth over the recent years, driven by the constant increase of demand from developed countries, introduction of new products and technological advancement in the medical industry. It is set to continue growing at a CARG of above 12% through 2015. Gilead Sciences, Merck & Co., GlaxoSmithKline, Bristol-Myers Squibb and Hoffmann-La Roche are amid the key hepatitis market players.

The collection of the research reports found in this catalogue provides an extensive insight into the hepatitis market at different geographical scales. Relevant information on the market size, share, segmentation as well as major factors influencing the market is presented in the researches. The reports offer detailed assessment of the competitive landscape and profile top companies. In addition, discussions of future market prospects for the are at hand in the research reports.

Found 161 publications
Hepatitis C [2016]: Bulletin #3 US$ 1,045.00

... presents key opinion leader (KOL) views on recent developments in the hepatitis C virus (HCV) infection market. Topics covered include: Medivir AB communicating ...

Jun, 2017
Global Hepatitis Drug Market & Clinical Trials Insight 2023 US$ 2,400.00

... Hepatitis C drugs. “Global Hepatitis Drug Market & Clinical Trials Insight 2023” report highlights: Prevalence of Hepatitis Infection Available Drug Classes for Hepatitis Drug Global Hepatitis Drug Market Analysis Global Hepatitis (A,B,C,D & E) Drug Clinical Pipeline Insight Marketed Hepatitis Drug Clinical ...

Jun, 2017 550 pages
2017 Global and Regional Human Hepatitis B Immunoglobulin (IM) Market Research Report Forecasts 2022 US$ 2,800.00

... etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia ... are as follows: 100IU/Bottle Human Hepatitis B Immunoglobulin (IM), 200IU/Bottle Human Hepatitis B Immunoglobulin (IM), 400IU/Bottle Human Hepatitis B Immunoglobulin (IM) Major applications ...

Jun, 2017 154 pages
2017 Global and Regional Human Hepatitis B Immunoglobulin (HBIG) Market Research Report Forecasts 2022 US$ 2,800.00

This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, ... etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China ...

Jul, 2017 159 pages
Global Hepatitis B Virus Core Antibody Diagnostic Kits Industry Market Research 2017 US$ 2,600.00

... ? 10. What are the Hepatitis B Virus Core Antibody Diagnostic Kits market opportunities and threats faced by the vendors in the global Hepatitis B Virus Core Antibody Diagnostic Kits market ... -segments of the global Hepatitis B Virus Core Antibody Diagnostic Kits market. 2. To provide insights about factors affecting the market growth. To analyze the Hepatitis B Virus Core Antibody Diagnostic ...

Jun, 2017 155 pages
The 2018-2023 World Outlook for Hepatitis C Treatments US$ 995.00

This study covers the world outlook for hepatitis C treatments across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Hepatitis C Therapies US$ 995.00

This study covers the world outlook for hepatitis C therapies across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Hepatitis B Therapeutics US$ 995.00

This study covers the world outlook for hepatitis B therapeutics across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 US$ 10,995.00 US$ 9,345.75

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 SUMMARY The hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic ... for viral resistance when HCV is treated with a single drug. During the last few years, the hepatitis C treatment landscape has experienced ...

Dec, 2016 499 pages
EpiCast Report: Hepatitis C Virus - Epidemiology Forecast to 2025 US$ 3,995.00 US$ 3,395.75

EpiCast Report: Hepatitis C Virus - Epidemiology Forecast to 2025 SUMMARY Hepatitis C is a blood-borne liver disease caused by the hepatitis C virus (HCV). HCV can cause both acute and chronic hepatitis ... comparison of the forecast numbers in these markets. SCOPE The Hepatitis C Virus (HCV) EpiCast Report provides an overview of the risk factors and global trends of HCV ...

Dec, 2016 102 pages
2017 World Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs-Supplier Shares and Strategies, Country Market... US$ 5,450.00

... , Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides ... NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...

Nov, 2016 320 pages
2017 US Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs-Supplier Shares, Competitive Strategies, Country Market... US$ 3,900.00

... report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...

Nov, 2016 241 pages
2017 UK Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Public Health Labs--Supplier Shares, Competitive Strategies, Country Market Segment Volume and... US$ 3,900.00

... report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...

Mar, 2017 241 pages
2017 Spain Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals-Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts... US$ 3,900.00

... . The report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...

Nov, 2016 241 pages
2017 France Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals-Supplier Shares and Strategies, Country Market Segment Volume and Sales Forecasts for... US$ 3,900.00

... . The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...

Nov, 2016 241 pages
Global Hepatitis B Virus (HBV) Market: 10-Year Demand Forecast (2016-2025) US$ 800.00

Hepatitis B is a virus that infects the liver. For most adults who suffer from it for a short time, it is called acute hepatitis B. Sometimes the virus causes ... legal regulations. The report “Global Hepatitis B Virus (HBV) Market – 10 Year Demand Forecast (2016-2025)” provides an in-depth analysis of the global market along with markets ...

Oct, 2016 69 pages
Hepatitis E Global Clinical Trials Review, H2, 2016 US$ 2,500.00 US$ 2,125.00

... clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial ...

Aug, 2016 31 pages
Global Hepatitis B and C Diagnostics Market 2016-2020 US$ 2,500.00

... serologic test used for screening. Technavio’s analysts forecast the global hepatitis B and C diagnostics market to grow at a CAGR of 6.35% during the period ... following segments based on geography: Americas APAC EMEA Technavio's report, Global Hepatitis B and C Diagnostics Market 2016-2020, has been prepared ...

Aug, 2016 110 pages
2017 World Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities US$ 9,500.00

... analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and ... Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: Hospitals ...

Mar, 2017 320 pages
2017 US Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities US$ 3,900.00

... (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume ...

Mar, 2017 241 pages
2017 UK Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities US$ 3,900.00

... (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume ...

Mar, 2017 241 pages
2017 Spain Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities US$ 3,900.00

... (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume ...

Mar, 2017 241 pages
2017 Japan Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities US$ 3,900.00

... (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume ...

Mar, 2017 241 pages
2017 Italy Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities US$ 3,900.00

... (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume ...

Mar, 2017 241 pages
2017 Germany Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities US$ 3,900.00

... (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume ...

Mar, 2017 241 pages
2017 France Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities US$ 3,900.00

... (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume ...

Mar, 2017 241 pages
2017 Europe Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities US$ 6,900.00

... report $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are ...

Mar, 2017 295 pages
Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016 US$ 3,500.00 US$ 2,975.00

... Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016’, provides in depth analysis on Hepatitis B Virus Core Antigen (HBcAg) targeted pipeline therapeutics. The report provides comprehensive information on the Hepatitis B Virus Core Antigen (HBcAg), targeted therapeutics ...

Jun, 2016 44 pages
Hepatitis C Virus (HCV) Envelope Protein E2 - Pipeline Review, H1 2016 US$ 3,500.00 US$ 2,975.00

... Hepatitis C Virus (HCV) Envelope Protein E2 - Pipeline Review, H1 2016’, provides in depth analysis on Hepatitis C Virus (HCV) Envelope Protein E2 targeted pipeline therapeutics. The report provides comprehensive information on the Hepatitis C Virus (HCV) Envelope Protein E2, targeted therapeutics ...

Jun, 2016 36 pages
2017 Spain Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts... US$ 3,900.00

... . The report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...

Mar, 2017 241 pages
2017 Japan Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts... US$ 3,900.00

... . The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...

Mar, 2017 241 pages
2017 Italy Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts... US$ 3,900.00

... . The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...

Mar, 2017 241 pages
Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis to 2024 US$ 4,995.00 US$ 4,245.75

Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis to 2024 Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the ...

Jan, 2016 209 pages
Hepatitis B Virus (HBV) Therapeutics - Japan Drug Forecast and Market Analysis to 2024 US$ 4,995.00 US$ 4,245.75

Hepatitis B Virus (HBV) Therapeutics - Japan Drug Forecast and Market Analysis to 2024 Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the ...

Jan, 2016 209 pages
Hepatitis B Virus (HBV) Therapeutics - Current and Future Players US$ 2,995.00 US$ 2,545.75

Hepatitis B Virus (HBV) Therapeutics - Current and Future Players Summary GlobalData has released its pharma report, “Hepatitis B Virus (HBV) Therapeutics - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HBV ...

Jan, 2016 84 pages
Hepatitis B Virus (HBV) Therapeutics - China Drug Forecast and Market Analysis to 2024 US$ 4,995.00 US$ 4,245.75

Hepatitis B Virus (HBV) Therapeutics - China Drug Forecast and Market Analysis to 2024 Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the ...

Jan, 2016 210 pages
Hepatitis B Virus (HBV) Therapeutics - 5EU Drug Forecast and Market Analysis to 2024 US$ 6,995.00 US$ 5,945.75

Hepatitis B Virus (HBV) Therapeutics - 5EU Drug Forecast and Market Analysis to 2024 Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the ...

Jan, 2016 210 pages
Hepatitis C: Update Bulletin [February 2016] US$ 995.00

... on the latest events that have the potential to shape the hepatitis C virus (HCV) treatment landscape. Topics covered include KOL ... if a short treatment regimen is attractive to KOLs. Key Questions Answered in this Update Bulletin: How do KOLs expect Merck & Co.’s Zepatier (elbasvir and grazoprevir) to be ...

Feb, 2016
Global Hepatitis C Virus (HCV) Market Report: 2016 Edition US$ 800.00

Hepatitis C Virus (HCV) is an infection which affects the liver which may lead to serious ... HCV market. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global HCV ...

Mar, 2016 60 pages
Hepatitis Global Clinical Trials Review, H2, 2015 US$ 2,500.00 US$ 2,125.00

... clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial ...

Dec, 2015 2252 pages
The 2018-2023 World Outlook for Hepatitis C Virus (HCV) Therapeutics US$ 995.00

This study covers the world outlook for hepatitis c virus (HCV) therapeutics across more than 190 ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 294 pages
Global Hepatitis Drugs Market 2015-2019 US$ 3,000.00

... period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of hepatitis. Technavio's report, Global Hepatitis Drugs Market 2015-2019 ...

Dec, 2015 118 pages
United States Prophylactic Hepatitis B Virus Vaccines Industry 2015 Market Research Report US$ 3,800.00

The United States Prophylactic Hepatitis B Virus Vaccines Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Prophylactic Hepatitis B Virus Vaccines industry ... and industry chain structure. The Prophylactic Hepatitis B Virus Vaccines market analysis is provided for the United States markets including development trends, competitive landscape ...

Dec, 2015 132 pages
Non-Alcoholic SteatoHepatitis (NASH): An Analysis of Disease Prevalence, Drugs in development, Regulatory guidelines and Market opportunity in Various Geographies US$ 3,500.00

... clinical trial in CY16 and this should accelerate the development of the drugs targeting NASH. NASH is the progressive form of Non-Alcoholic Fatty Liver Disease – NAFLD. While NASH ...

Dec, 2015 65 pages
Global Prophylactic Hepatitis B Virus Vaccines Industry 2015 Market Research Report US$ 2,800.00

The Global Prophylactic Hepatitis B Virus Vaccines Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Prophylactic Hepatitis B Virus Vaccines industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Prophylactic Hepatitis B Virus ...

Nov, 2015 157 pages
2016 Europe Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices - Supplier Shares and Country Sales Segment Forecasts for 10... US$ 6,900.00

... $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology ...

Nov, 2015 295 pages
Global Human Hepatitis B Immunoglobulin Industry 2015 Market Research Report US$ 2,850.00

2015 Global Human Hepatitis B Immunoglobulin Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Human Hepatitis B Immunoglobulin industry, focusing on the ... with: 1.) basic information; 2.) the Asia Human Hepatitis B Immunoglobulin industry; 3.) the North American Human Hepatitis B Immunoglobulin industry; 4.) the European Human Hepatitis B Immunoglobulin industry; 5.) market entry and investment feasibility ...

Oct, 2015 167 pages
2016 Future Horizons and Growth Strategies in the US Hepatitis Diagnostic Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities US$ 3,900.00

Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test ...

Nov, 2015 241 pages
2016 Future Horizons and Growth Strategies in the UK Hepatitis Diagnostic Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities US$ 3,900.00

Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test ...

Nov, 2015 241 pages
2016 Future Horizons and Growth Strategies in the Spanish Hepatitis Diagnostic Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities US$ 3,900.00

... . The report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology ...

Nov, 2015 241 pages
1 2 3 4 >
Skip to top